Delivery Order SPE2DB22D9367-SPE2DB24FSU81

Award Date 10/25/23
Potential Completion Date 11/16/23
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand six hundred sixty-seven dollars and seventy cents ($1,667.70) by the Defense Logistics Agency to supply ZOSYN 3.375 GM/50 ML GALAXY 50ML. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. As a...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand two hundred eighty dollars and fifty-two cents ($1,280.52) by the Defense Logistics Agency to provide ZOSYN 4.5 GM/100 ML GALAXY BAG 100ML. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical products with a potential value of up to five million dollars through December 2025. No...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to supply ZOSYN 3.375 GM/50 ML GALAXY 50ML. The $1,111.80 delivery order has a period of performance through November 2023 and will fulfill requirements for the pharmaceutical item to support military treatment facilities overseen by the Defense Logistics Agency. DMS Pharmaceutical Group holds additional delivery orders and an indefinite...
The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide ZOSYN 3.375 GM/50 ML GALAXY 50ML pharmaceutical supplies. The contract is valued at $1,659.40 and has a completion date of January 19, 2024. DMS Pharmaceutical Group is an experienced federal contractor that holds numerous indefinite delivery contracts with the Defense Logistics Agency to supply a wide range of pharmaceutical and medical products in...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,327.60, is for the delivery of ZOSYN 3.375 GM/50 ML GALAXY 50ML pharmaceutical products. DMS Pharmaceutical Group Inc. holds a broader indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, valued up to $4,999,999 through 2025, which enables DLA to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,322.36 contract is for the delivery of Zosyn 3.375 GM/50 ML GALAXY 50ML, a pharmaceutical product. The contract has an ultimate completion date of October 19, 2021 and is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract with the DLA under...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $2,812.00 awarded by the Defense Logistics Agency (DLA) under the SPE2DB program. The award covers the supply of ZOSYN 3.375 GM/50 ML GALAXY 50ML, a pharmaceutical product, with a completion date of December 28, 2022. DMS Pharmaceutical Group Inc. holds a large indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,243.84 contract covers the delivery of 4567537209 - ZOSYN 3.375 GM/50 ML GALAXY 50ML, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. The contract has an ultimate completion date of March 18, 2025. DMS Pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,000.32, is for the delivery of the pharmaceutical product ZOSYN 3.375 GM/50 ML GALAXY 50ML to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of April 9, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, to provide the pharmaceutical product ZOSYN 3.375 GM/50 ML GALAXY 50ML. The contract has a potential value of $2,166.64 and a completion date of March 19, 2024. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with DLA, which has a total potential value of up to $4,999,999 through...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSU81
    Delivery Order

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at three thousand four hundred twenty four dollars and eighty cents ($3,424.80) by the Defense Logistics Agency (DLA) to supply ZOSYN 3.375 GM/50 ML GALAXY 50ML pharmaceutical products. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with DLA to provide various medical supplies with a potential value of up to five million dollars through December 2025. As a woman-owned small business and pharmaceutical wholesaler, DMS Pharmaceutical Group maintains numerous contracts to support the routine needs of military treatment facilities overseen by DLA worldwide through the delivery of brand and generic prescription drugs, over-the-counter medications, and medical products.

Generated 1/24/24, 9:49 AM